If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Edison issues initiation on De La Rue (DLAR)

14 Jan 2019 14:20

Edison Investment Research Limited Edison issues initiation on De La Rue (DLAR) 14-Jan-2019 / 14:19 GMT/BST


London, UK, 14 January 2019

Edison issues initiation on De La Rue (DLAR)

De La Rue (DLAR) continues to pursue a strategy that is transitioning the company to a less capital-intensive operation with a more diverse customer base and revenue streams, incorporating more embedded technology and IP. Underlying progress is apparent although masked by the disposals and the recent loss of the UK passport contract. The strengthening of the balance sheet enables appropriate M&A to augment what we expect to be a resumption of organic sales growth from FY21. The current rating implies scepticism but this should improve as growth prospects are recognised. In the meantime, the healthy dividend yield provides support for investors.

Our fair value DCF returns a value of 639p a share, a healthy 49% premium to the current share price. The implied P/E for FY20e of 13.9x is hardly demanding compared to the support services segment calendar 2019 P/E multiple of 14.8x. In our view, the current rating of 9.7x FY20 EPS with a yield of 5.8% does not reflect growth potential.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Andy Chambers, +44 (0)20 3681 2525industrials@edisongroup.comLearn more at www.edisongroup.com and connect with Edison on:LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_ResYouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

765863 14-Jan-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
23rd Nov 20227:00 amRNS2022/23 HALF YEAR RESULTS
22nd Nov 202210:39 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSResponse to Crystal Amber's open letter
3rd Nov 20222:33 pmRNSNotice of GM
27th Oct 20221:00 pmRNSDE LA RUE PLC ANNOUNCES GENERAL MEETING
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn
30th Sep 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSExtension of contract
13th Sep 202210:58 amRNSDirectorate Change
2nd Sep 20227:00 amRNSExecutive Changes in Authentication Division
1st Sep 202212:10 pmRNSDirector/PDMR Shareholding
10th Aug 20221:55 pmRNSDirector/PDMR Shareholding
1st Aug 202210:01 amRNSTotal Voting Rights
27th Jul 202211:53 amRNSResult of AGM
26th Jul 20225:11 pmRNSTERMINATION OF RELATIONSHIP AGREEMENT WITH PORTALS
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
6th Jul 20221:47 pmRNSDirector/PDMR Shareholding
1st Jul 202210:46 amRNSBlock listing Interim Review
1st Jul 202210:40 amRNSTotal Voting Rights
24th Jun 202210:21 amRNSAnnual Financial Report
9th Jun 20221:38 pmRNSHolding(s) in Company
31st May 20229:25 amRNSHolding(s) in Company
25th May 20227:00 amRNSFY22 Full Year Results
23rd May 20221:03 pmRNSAdditional Listing
7th Apr 20227:00 amRNSTrading Update
1st Apr 202210:17 amRNSTotal Voting Rights
18th Mar 20227:00 amRNSUpdate on Responsible Business Activities
11th Mar 202210:45 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPension Scheme funding update
1st Mar 202210:44 amRNSTotal Voting Rights
3rd Feb 20227:00 amRNSAuthentication Contract Win
1st Feb 20229:44 amRNSTotal Voting Rights
26th Jan 20222:46 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSTrading and Turnaround Plan Update
12th Jan 20225:48 pmRNSChange in Director's Particulars
5th Jan 20224:37 pmRNSDirector/PDMR Shareholding
4th Jan 202212:06 pmRNSBlock listing Interim Review
4th Jan 202212:02 pmRNSTotal Voting Rights
1st Dec 202111:59 amRNSTotal Voting Rights
24th Nov 20217:00 amRNS2021/22 HALF YEAR RESULTS
1st Nov 202111:55 amRNSTotal Voting Rights
15th Oct 202110:08 amRNSHolding(s) in Company
12th Oct 20217:00 amRNSTrading Statement
1st Oct 20212:24 pmRNSTotal Voting Rights
15th Sep 20217:00 amRNSAnnouncement Of Significant Expansion In Malta
1st Sep 202111:00 amRNSTotal Voting Rights
4th Aug 202111:30 amRNSHolding(s) in Company
2nd Aug 20219:58 amRNSTotal Voting Rights
29th Jul 20211:36 pmRNSResult of AGM
29th Jul 20217:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.